Clinical Trial Update: Paclitaxel in Patients With GIST With Low P-glycoprotein Expression After Failure of at Least Imatinib and Sunitinib, and Regorafenib. [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating paclitaxel in gastrointestinal stromal tumor patients with low P-glycoprotein expression after failure of imatinib, sunitinib, and re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrointestinal Stromal Tumor

Drugs mentioned

• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Asan Medical Center | Conditions: Gastrointestinal Stromal Tumors | Phase 2 | Status: COMPLETED